Literature DB >> 2516717

Metastatic ability and differentiative properties of a new cell line of human embryonal rhabdomyosarcoma (CCA).

C De Giovanni1, P Nanni, G Nicoletti, C Ceccarelli, K Scotlandi, L Landuzzi, P L Lollini.   

Abstract

A new cell line (CCA) was established from a human embryonal rhabdomyosarcoma. It showed an "early" myogenic differentiation pattern: vimentin expression was found in 100% of cells, desmin in about 40% and myosin of the embryonic isoform in about 5%. Class I HLA expression on CCA cells was undeterctable but was greatly increased by in vitro treatment with human recombinant interferon-gamma and only marginally increased by human recombinant tumour necrosis factor-alfa. CCA cell line was tumorigenic in nude mice after either subcutaneous or intramuscular injection; macroscopic spontaneous metastases were not detected. The ability to induce metastatic nodules in the lungs was found when CCA cells were injected intravenously in cyclophosphamide-pretreated nude mice and, at low frequency, in untreated nude mice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2516717

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  A Novel Notch-YAP Circuit Drives Stemness and Tumorigenesis in Embryonal Rhabdomyosarcoma.

Authors:  Katherine K Slemmons; Lisa E S Crose; Stefan Riedel; Manuela Sushnitha; Brian Belyea; Corinne M Linardic
Journal:  Mol Cancer Res       Date:  2017-09-18       Impact factor: 5.852

2.  Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway.

Authors:  Ulrica Tostar; Rune Toftgård; Peter G Zaphiropoulos; Takashi Shimokawa
Journal:  Genes Cancer       Date:  2010-09

3.  The expression of ccn3(nov) gene in musculoskeletal tumors.

Authors:  Maria Cristina Manara; Bernard Perbal; Stefania Benini; Rosaria Strammiello; Vanessa Cerisano; Stefania Perdichizzi; Massimo Serra; Annalisa Astolfi; Franco Bertoni; Jennifer Alami; Herman Yeger; Piero Picci; Katia Scotlandi
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

4.  Overexpression of the skNAC gene in human rhabdomyosarcoma cells enhances their differentiation potential and inhibits tumor cell growth and spreading.

Authors:  Janine Berkholz; Weronika Kuzyniak; Michael Hoepfner; Barbara Munz
Journal:  Clin Exp Metastasis       Date:  2014-09-11       Impact factor: 5.150

5.  Induction of myogenic differentiation in human rhabdomyosarcoma cells by ionising radiation, N,N-dimethylformamide and their combination.

Authors:  G Nicoletti; C De Giovanni; L Landuzzi; G Simone; P Rocchi; P Nanni; P L Lollini
Journal:  Br J Cancer       Date:  1992-04       Impact factor: 7.640

6.  Restoration of p16INK4A protein induces myogenic differentiation in RD rhabdomyosarcoma cells.

Authors:  M Urashima; G Teoh; M Akiyama; Y Yuza; K C Anderson; K Maekawa
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

7.  Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Authors:  Ashley R P Hinson; Rosanne Jones; Lisa E S Crose; Brian C Belyea; Frederic G Barr; Corinne M Linardic
Journal:  Front Oncol       Date:  2013-07-17       Impact factor: 6.244

8.  Metformin as an adjuvant drug against pediatric sarcomas: hypoxia limits therapeutic effects of the drug.

Authors:  Cecilia Garofalo; Mariantonietta Capristo; Maria Cristina Manara; Caterina Mancarella; Lorena Landuzzi; Antonino Belfiore; Pier-Luigi Lollini; Piero Picci; Katia Scotlandi
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

9.  Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin.

Authors:  C De Giovanni; C Melani; P Nanni; L Landuzzi; G Nicoletti; F Frabetti; C Griffoni; M P Colombo; P L Lollini
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

10.  MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.

Authors:  Lucia Tombolan; Matteo Zampini; Silvia Casara; Elena Boldrin; Angelica Zin; Gianni Bisogno; Angelo Rosolen; Cristiano De Pittà; Gerolamo Lanfranchi
Journal:  PLoS One       Date:  2015-04-27       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.